Abstract: The ethanolic extracts of Eucommia ulmoides Oliv. leaves were isolated and purified, where thirteen compounds were obtained, including one new compound and twelve known compounds. The structures of the compounds were identified by spectral data as follows: (R, 9Z, 12E, 15Z)-11-hydroxyoctadeca-9, 12, 15-trienoic acid(1), 7-hydroxycoumarin(2), astragaline(3), quercetine(4), quercetin-3-O-glucoside(5), 2-(3, 4-dihydroxyphenyl)-5, 7-dihydroxy-3-(3-O-α-D-xylopyranosyl-α-D-galactopy-ranosyl)oxy-4H-1-benzopyran-4-one(6), (2R, 3S)-3-(4-hydroxy-3-methoxyphenyl)-3-methoxypropane-1, 2-diol(7), (2S, 3R)-3-(4-hydroxy-3-methoxyphenyl)-3-methoxypropane-1, 2-diol(8), chlorogenic acid(9), gardendiol(10), 4-benzyloxy benzoic acid(11), vanillic acid(12) and myristic acid(13). Among them, compound 1 was a new fatty acid compound. The anti-neuroinflammatory and neuroprotective activities of 13 compounds were studied. The results showed that compounds 4, 5 and 10 exhibited significant anti-neuroinflammatory activity by inhibiting the release of nitric oxide(NO) production in lipopolysaccharide(LPS)-induced in mouse microglia(BV-2 cells), with half inhibitory concentration(IC₅₀) values of (10.8±0.9), (9.7±1.1) and (10.7±0.3) μmol/L, respectively. Compound 5 exhibited significant neuroprotective activity under oxidative stress. After pretreatment with 20 μmol/L H₂O₂-induced rat adrenal pheochromocytoma cells(PC-12 cells), the cell survival rate was (86.5±0.5)%, which was higher than that of the positive control hesperidin.